Shopping Cart
Remove All
Your shopping cart is currently empty
MYBMIM is an inhibitor of the MYB:CBP/P300 assembly complex [MYB:CBP/P300]. It suppresses the growth of leukemia cells.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | MYBMIM is an inhibitor of the MYB:CBP/P300 assembly complex [MYB:CBP/P300]. It suppresses the growth of leukemia cells. |
| In vitro | MYBMIM (10-20 μM) inhibits the proliferation of acute myeloid leukemia cells over 6 days and induces apoptosis within 48 hours by downregulating the expression of the anti-apoptotic Bcl2 gene. |
| In vivo | MYBMIM (25 mg/kg, administered intraperitoneally twice daily for 14 consecutive days) effectively inhibits the progression of human leukemia tumors in a mouse xenograft model. |
| Formula | C166H296N60O45S |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.